The guanine nucleotide exchange factor CNrasGEF activates Ras in response to cAMP and cGMP  by Pham, N et al.
R577
Erratum
The guanine nucleotide exchange factor CNrasGEF activates Ras in response to
cAMP and cGMP
N. Pham, I. Cheglakov, C.A. Koch, C.L. de Hoog, M.F. Moran and D. Rotin
Current Biology 2000, Vol 10 No 9:555–558
In this Brief Communication, which appeared in the 4 May 2000 issue of Current Biology, some of the labels on Figure 3
were incorrect: the corrected figure appears on the next page. In (d,e,g), the labels CDC25 and cNMP-BD should have
been ∆CDC25 and ∆cNMP-BD and, in the middle panel of (g), the lysate was probed with anti-Rap1 antibodies (not
anti-Ras antibodies).
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cAMP/cGMP-mediated activation of Ras by CNrasGEF in living cells.
(a) cAMP-dependent and PKA-independent activation of Ras by
CNrasGEF. HEK-293T cells were transfected (or not) with
FLAG-tagged CNrasGEF, serum-starved overnight and treated with
the indicated compounds (see Supplementary material). Cells were
then lysed and lysate incubated with immobilized RBD of Raf1
(GST–Raf1(RBD)). Co-precipitated activated Ras was then detected
with anti-Ras antibodies (upper panel). The lower two panels depict
the amounts of total endogenous Ras and of the transfected
CNrasGEF (detected with anti-Ras and anti-FLAG antibodies,
respectively). On average, 8-Br-cAMP activated CNrasGEF 9.7-fold,
determined by densitometry (n = 7). (b) cGMP-dependent and
PKG-independent activation of Ras by CNrasGEF. The experiment
was performed as in (a) but using the different compounds indicated.
On average, 8-Br-cGMP activated CNrasGEF 10.4-fold, determined
by densitometry (n = 3). (c) Activation of Ras via CNrasGEF following
elevation of intracellular levels of cAMP or cGMP. Cells were
transfected as in (a), and treated with the indicated compounds.
Parallel treatments with 8-Br-cAMP or 8-Br-cGMP were used as
positive controls. Lysates of treated cells were then incubated with
GST–Raf1(RBD) to precipitate activated Ras as in (a).
(d) Requirement of the cNMP-BD and the CDC25 domain of
CNrasGEF for cAMP-mediated Ras activation. Cells were transfected
with vector alone, wild-type, ∆cNMP-BD or ∆CDC25 CNrasGEF, and
then treated (or not) with 8-Br-cAMP. Cell lysates were then
incubated with GST–Raf1(RBD) and treated as in (a). (e) In vitro
activation of Ras by CNrasGEF. Wild-type CNrasGEF, ∆CDC25
CNrasGEF or GRF2, each FLAG-tagged, were immunoprecipitated
from transfected Hek-293T cells using anti-FLAG antibodies. Equal
amounts of washed immunoprecipitates were incubated with
[α-32P]GTP plus Ras for 30 min. Bound and unbound radiolabeled
GTP were then separated by filtration and the amount of bound GTP
determined by scintillation counting. Fold Ras activation compared to
the activation of Ras in the absence of GRFs (white) is plotted. The
number of independent experiments (n), in duplicates, is indicated.
(f) cAMP-independent activation of GRF2 in HEK-293T cells. Cells
were transfected with vector alone or with FLAG-tagged GRF2, and
treated (or not) with 8-Br-cAMP. Cell lysate was then incubated with
GST–Raf1(RBD) and processed as in (a). (g) Constitutive,
cAMP-independent but CDC25-dependent activation of Rap1 by
CNrasGEF. HEK-293T cells were transfected with vector alone,
wild-type or ∆CDC25 CNrasGEF, treated (or not) with 8-Br-cAMP,
and cell lysates incubated with GST–RalGDS(RBD) (upper panel).
Total cellular Rap1 was detected with anti-Rap1 antibodies (middle
panel) and transfected CNrasGEF and the mutant were detected with
anti-FLAG antibodies (lower panel), as above. Autoradiograms are
representative of 2–8 independent experiments. Abbreviations are
listed in the Supplementary material.
